Navigation Links
Standard treatments for head and neck cancer less effective in HIV-positive patients
Date:1/26/2012

Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

Treating head and neck cancer in HIV-positive patients is a challenge for oncologists. Because of the advancements in treating HIV, these patients are living much longer and therefore have a much higher chance of developing an HIV-related cancer. However, despite using treatments that are successful in HIV-negative cancer patients, HIV-positive patients experience much worse outcomes.

In the largest single institution study of its kind, researchers retrospectively studied 71 HIV-positive head and neck cancer patients treated between 1997 and 2010. Patients were followed for approximately 47 months and the rates of recurrence and overall survival were very high at 69 percent and 55 percent, respectively. Ten percent of patients also developed a second primary malignancy within five years after receiving radiation therapy.

The study authors concluded that neither radiation nor radiation plus chemotherapy, both standard treatments for head and neck cancer, were as effective for HIV-positive patients when compared to HIV-negative patients and that more research was needed to develop treatments that can reduce the risk of recurrence and increase survival rates.

"Treating HIV-positive patients with head and neck cancers is extremely difficult, but becoming much more commonplace due to the advances in therapies that prolong the life of these patients," Waleed Mourad, MD, MSc, PhD, lead author of the study and a radiation oncologist at Beth Israel Medical Center in New York, said. "It is extremely important that we establish multimodality approaches and regimens that are better tailored to improve outcomes in HIV-positive head and neck cancer patients and minimize treated related co-morbidities."


'/>"/>
Contact: Nicole Napoli
nicolen@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
2. Pharmahelper Pleased To Recognize Online Pharmacy Practice Standards Announced By Google Adwords
3. ATS, ERS issue official standards for the quantitative assessment of lung structure
4. Sacred Heart Medical Center Cited for Violation of Safety Standards in H1N1 Prevention
5. Figure Skating Standards Foster Eating Disorders, Says Kimberly Dennis, M.D.
6. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
7. Innovative Medical Alert Device Sets a New Standard in PERS Industry
8. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
9. MedInformatix EPM and EMR Standardizes Care, Raises Efficiency for Affiliates of Non-Profit Physicians Network
10. Physician calls for more rigorous standards for drugs up for FDA approval
11. Irelands Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a family ... and Raleigh regions, is organizing an extended charity drive to benefit the family ... abnormality. , After struggling since birth with several health challenges, T.J. was later ...
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
Breaking Medicine Technology: